IOL Chemicals & Pharmaceuticals rose 1.27% to Rs 103.85 at 13:12 IST on BSE after the company reported net profit of Rs 1.13 crore in Q4 March 2016 as compared to net loss of Rs 28.06 crore in Q4 March 2015.
The company announced the result after market hours yesterday, 2 May 2016.Meanwhile, the S&P BSE Sensex was down 138.32 points, or 0.54%, to 25,298.65
On BSE, so far 1.23 lakh shares were traded in the counter, compared with an average volume of 55,210 shares in the past one quarter. The stock hit a high of Rs 110.50 and a low of Rs 103.15 so far during the day. The stock had hit a 52-week high of Rs 113.90 on 21 July 2015. The stock had hit a 52-week low of Rs 44.15 on 12 May 2015. The small-cap stock had outperformed the market over the past one month till 2 May 2016, gaining 32.32% compared with 0.66% gains in the Sensex. The scrip also outperformed the market in past one quarter, surging 48.19% as against Sensex's 3.66% gains.
The company has equity capital of Rs 56.21 crore. Face value per share is Rs 10.
IOL Chemicals & Pharmaceuticals' total income surged 89.3% to Rs 142.47 crore in Q4 March 2016 over Q4 March 2015. The company is in process of adding new pharma products in near future, which will add value to existing portfolio and enabling to broaden its global market, IOL Chemicals & Pharmaceuticals said.
IOL Chemicals and Pharmaceuticals is one of the leading generic pharmaceuticals companies and is significant player in the speciality chemicals space.
Powered by Capital Market - Live News